165 related articles for article (PubMed ID: 8744510)
41. A prospective survey of current methicillin-resistant Staphylococcus aureus control measures.
Barakate MS; Harris JP; West RH; Vickery AM; Sharp CA; Macleod C; Benn RA
Aust N Z J Surg; 1999 Oct; 69(10):712-6. PubMed ID: 10527347
[TBL] [Abstract][Full Text] [Related]
42. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.
Robicsek A; Beaumont JL; Paule SM; Hacek DM; Thomson RB; Kaul KL; King P; Peterson LR
Ann Intern Med; 2008 Mar; 148(6):409-18. PubMed ID: 18347349
[TBL] [Abstract][Full Text] [Related]
43. Nasal mupirocin treatment of pharynx-colonized methicillin resistant Staphylococcus aureus: preliminary study with 10 carrier infants.
Hayakawa T; Hayashidera T; Katsura S; Yoneda K; Kusunoki T
Pediatr Int; 2000 Feb; 42(1):67-70. PubMed ID: 10703239
[TBL] [Abstract][Full Text] [Related]
44. Outbreak of methicillin-resistant Staphylococcus aureus colonization and infection in a neonatal intensive care unit epidemiologically linked to a healthcare worker with chronic otitis.
Bertin ML; Vinski J; Schmitt S; Sabella C; Danziger-Isakov L; McHugh M; Procop GW; Hall G; Gordon SM; Goldfarb J
Infect Control Hosp Epidemiol; 2006 Jun; 27(6):581-5. PubMed ID: 16755477
[TBL] [Abstract][Full Text] [Related]
45. Cost Efficacy of Methicillin-Resistant Staphylococcus aureus Decolonization With Intranasal Povidone-Iodine.
Rieser GR; Moskal JT
J Arthroplasty; 2018 Jun; 33(6):1652-1655. PubMed ID: 29506927
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of a program of prevention and control for methicillin-resistant Staphylococcus aureus infections in an intensive-care unit.
Moreira M; Freitas MR; Martins ST; Castelo A; Medeiros EA
Braz J Infect Dis; 2007 Feb; 11(1):57-62. PubMed ID: 17625729
[TBL] [Abstract][Full Text] [Related]
47. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection.
Muder RR; Cunningham C; McCray E; Squier C; Perreiah P; Jain R; Sinkowitz-Cochran RL; Jernigan JA
Infect Control Hosp Epidemiol; 2008 Aug; 29(8):702-8, 7 p following 708. PubMed ID: 18624651
[TBL] [Abstract][Full Text] [Related]
48. Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSA.
Casewell MW; Hill RL
J Hosp Infect; 1991 Sep; 19 Suppl B():35-40. PubMed ID: 1684191
[TBL] [Abstract][Full Text] [Related]
49. Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin.
Irish D; Eltringham I; Teall A; Pickett H; Farelly H; Reith S; Woodford N; Cookson B
J Hosp Infect; 1998 May; 39(1):19-26. PubMed ID: 9617681
[TBL] [Abstract][Full Text] [Related]
50. A purpose built MRSA cohort unit.
Fitzpatrick F; Murphy OM; Brady A; Prout S; Fenelon LE
J Hosp Infect; 2000 Dec; 46(4):271-9. PubMed ID: 11170758
[TBL] [Abstract][Full Text] [Related]
51. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies.
Trautmann M; Stecher J; Hemmer W; Luz K; Panknin HT
Chemotherapy; 2008; 54(1):9-16. PubMed ID: 18063862
[TBL] [Abstract][Full Text] [Related]
52. Low prevalence of mupirocin resistance among hospital-acquired methicillin-resistant Staphylococcus aureus isolates in a neonatal intensive care unit with an active surveillance cultures and decolonization program.
Suwantarat N; Carroll KC; Tekle T; Ross T; Popoola VO; Milstone AM
Infect Control Hosp Epidemiol; 2015 Feb; 36(2):232-4. PubMed ID: 25633010
[No Abstract] [Full Text] [Related]
53. Nasal carriage of Staphylococcus aureus and cross-contamination in a surgical intensive care unit: efficacy of mupirocin ointment.
Talon D; Rouget C; Cailleaux V; Bailly P; Thouverez M; Barale F; Michel-Briand Y
J Hosp Infect; 1995 May; 30(1):39-49. PubMed ID: 7665881
[TBL] [Abstract][Full Text] [Related]
54. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital.
Vasquez JE; Walker ES; Franzus BW; Overbay BK; Reagan DR; Sarubbi FA
Infect Control Hosp Epidemiol; 2000 Jul; 21(7):459-64. PubMed ID: 10926396
[TBL] [Abstract][Full Text] [Related]
55. [Control of methicillin resistant staphylococci at the Sahlgrenska hospital. Successful control program against MRSA outbreak].
Haglind E; Brantervik A; Friman S; Jertborn M; Rödjer S; Seeberg S
Lakartidningen; 2001 Nov; 98(47):5312-3. PubMed ID: 11763628
[TBL] [Abstract][Full Text] [Related]
56. Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin.
Maraha B; van Halteren J; Verzijl JM; Wintermans RG; Buiting AG
Clin Microbiol Infect; 2002 Oct; 8(10):671-5. PubMed ID: 12390287
[TBL] [Abstract][Full Text] [Related]
57. An outbreak of methicillin-resistant Staphylococcus aureus (M.R.S.A.) in a burn unit.
Danchivijitr S; Chokloikaew S; Chantrasakul C; Trakoolsomboon S
J Med Assoc Thai; 1995 Jul; 78 Suppl 1():S11-4. PubMed ID: 7666020
[TBL] [Abstract][Full Text] [Related]
58. Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.
Hill RL; Duckworth GJ; Casewell MW
J Antimicrob Chemother; 1988 Sep; 22(3):377-84. PubMed ID: 3141347
[TBL] [Abstract][Full Text] [Related]
59. Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: morbidity, mortality, and glycopeptide use.
Garrouste-Orgeas M; Timsit JF; Kallel H; Ben Ali A; Dumay MF; Paoli B; Misset B; Carlet J
Infect Control Hosp Epidemiol; 2001 Nov; 22(11):687-92. PubMed ID: 11842988
[TBL] [Abstract][Full Text] [Related]
60. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization.
Simor AE; Phillips E; McGeer A; Konvalinka A; Loeb M; Devlin HR; Kiss A
Clin Infect Dis; 2007 Jan; 44(2):178-85. PubMed ID: 17173213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
